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We read with interest the article published by Bird et al about the reproducibility of measured GFR by iohexol 
and Cr-51-EDTA [1]. We would like to make one comment and to share our own results on this fundamental 
(although understudied) topic. As we already pointed out in a NDT editorial, we share the same reserves about 
the opportunity to index glomerular filtration rate (GFR) with body surface area [2]. Indexing GFR with 
extracellular fluid volume (ECV) may be viewed as more logical as one of the major functions of the kidney is to 
regulate ECV. However, the fact that reproducibility of the GFR is better when indexed with ECV than when 
indexed with BSA is not the definite proof to use ECV indexation. The only proof would be to have an absolute 
correlation between GFR and ECV and that this relationship would totally disappear between indexed GFR and 
ECV [2]. For these reasons, we think that reproducibility of GFR measurement must be calculated from absolute, 
non-indexed GFR. Can Bird et al give the reproducibility of their non-indexed GFR? 
We have recently published our data regarding the reproducibility of serum creatinine and cystatin C with 
concomitant measurement of GFR [3]. Briefly, we have simultaneously measured GFR using the plasma 
clearance of iohexol and Cr-51-EDTA after 120 and 240 minutes as described by Brochner-Mortensen within a 
one week interval [4]. Our results in twelve healthy and fasting subjects show a slightly better reproducibility for 
iohexol (4.5%) than for Cr-51-EDTA (7.4%). Comparing to the Bird et al results, our data show relatively the 
same reproducibility for GFR measured with Cr-51-EDTA (and are somewhat similar to results published 
previously with 51Cr-EDTA plasma clearances (9.0 ± 5.3%)[5]), although the reproducibility of GFR measured 
with iohexol is better. Discrepancies between the results can be explained in part by differences in the 
methodology of the studies. What is of interest is that we have measured iohexol with a HPLC method. This 
method is probably more precise than the method used by Bird et al, namely X-ray fluorescence. From an 
analytical point of view, the HPLC method has been strongly and deeply validated (E. Cavalier, submitted), 
including in the low values (40 to 600 µg/ml), which are routinely measured. In this range, the method used by 
Bird et al seems less precise [6] and, in any case, has not been validated in their figure 1 (notably, the intercept in 
this figure is far from negligible). "Analytically" speaking, iohexol concentrations lower than 600 µg/ml are not 
precise enough to be used in the study by Bird et al. From our experience, such a level of concentration can be 
reached with the methodology used in this study (injection of 20 mL Omnipaque® 300). As analytical variance 
is included in the global reproducibility, this point must be underlined and can explain the better reproducibility 
observed using the "HPLC" iohexol in our data. 
We have no conflict of interest to declare 
References 
1.   Bird NJ, Peters C, Michell AR, Peters AM. Reproducibilities and responses to food intake of GFR measured with chromium-51-EDTA 
and iohexol simultaneously and independently in normal subjects. Nephrol Dial Transplant 2008; 23: 1902-1909 
2.   Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM. Indexing glomerular filtration rate for body surface area in obese 
patients is misleading: concept and example. Nephrol Dial Transplant 2005; 20: 2024-2028 
3.   Delanaye P, Cavalier E, Depas G, Chapelle JP, Krzesinski JM. New data on the intraindividual variation of cystatin C. Nephron Clin 
Pract 2008; 108: c246-c248 
4.   Brochner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-274 
5.   Froissait M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and 
Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 2005; 16: 763-773 
6.   Brandstrom E, Grzegorczyk A, Jacobsson L et al. GFR measurement with iohexol and 51Cr-EDTA. A comparison of the two favoured 
GFR markers in Europe. Nephrol Dial Transplant 1998; 13: 1176-1182 
Published in: Nephrology Dialysis Transplantation (2008), vol. 23, iss. 12, pp. 4077-8; author reply 4078. 
Status: Postprint (Author’s version) 
 
Reply to NDT 976-2008 
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Sir, 
We are grateful to Delanaye et al for their interesting comments concerning indexed GFR. 
We would like to make several points. 
1.   We do not think we claimed that better reproducibility was proof that indexing to extracellular fluid volume 
(ECV) was better than indexing to body surface area (BSA). 
2.   We presume that the only available proof referred to by Delanaye et al, namely an absolute correlation 
between GFR and ECV and its disappearance when using indexed values, refers to indexing with ECV. 
Correlating GFR indexed to ECV (GFR/ECV) and ECV itself is only valid with an independent measure of 
ECV, so in our dual indicator studies we examined these relations in 20 normal subjects studied under fasting 
and non-fasting conditions using GFR measured with one indicator and ECV simultaneously and independently 
measured with the other (1). As would be expected from the variation in subject size, absolute GFR and ECV 
correlated positively with each other, although only modestly (n = 40; r = 0.66 and 0.46 when GFR was 
measured with Cr-51-EDTA and iohexol, respectively). These coefficients are similar to those obtained when 
GFR was correlated with BSA (r = 0.57 and 0.59, respectively), although allowance should considered for the 
fact that measurement of BSA is probably more precise than that of ECV. GFR/ECV, however, correlated 
inversely with ECV/BSA (but inconsistently; thus only when the former was measured with iohexol and the 
latter with Cr-51-EDTA but not vice versa), whereas GFR/BSA correlated positively with ECV/BSA (but only 
when the former was measured with Cr-51-EDTA and the latter with iohexol) (1). We interpreted this to be 
consistent with the notion that, in normal subjects, expansion of ECV leads to a corresponding increase in 
GFR/BSA but that this increase is not proportionate, leading to a fall in GFR/ECV. 
3.   In any event, reproducibility of non-indexed fasting GFR will be the same as indexed GFR unless BSA 
changed between the 2 studies. Since these were close together, it did not. 
We would agree that, in general, the poorer reproducibility we found with iohexol was probably the result of the 
X-ray fluorescence (XRF) method we used. We did implement an HPLC method, in parallel with XRF, towards 
the end of our study and recorded reproducibility data for 3 subjects that were extremely promising. 
Yours 
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